|
Volumn 26, Issue 1, 2004, Pages 63-66
|
Epstein-Barr Virus-induced Transformation of Cutaneous Plasmacytoma into CD30+ Diffuse Large B-cell Lymphoma
|
Author keywords
EBV; Immunohistochemistry; Plasmacytoma; Skin
|
Indexed keywords
CD20 ANTIGEN;
CD30 ANTIGEN;
CD45 ANTIGEN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPSTEIN BARR VIRUS ANTIGEN;
LATENT MEMBRANE PROTEIN 1;
LEUKOSIALIN;
PREDNISONE;
RITUXIMAB;
VINCRISTINE;
AGED;
ANTIGEN EXPRESSION;
ARTICLE;
B CELL LYMPHOMA;
BLAST CELL;
CARCINOGENESIS;
CASE REPORT;
CELL TYPE;
CLINICAL FEATURE;
EPSTEIN BARR VIRUS;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
IMMUNOPHENOTYPING;
MALIGNANT TRANSFORMATION;
PLASMA CELL;
PLASMACYTOMA;
PRIORITY JOURNAL;
AGED;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD30;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CELL TRANSFORMATION, NEOPLASTIC;
CYCLOPHOSPHAMIDE;
EPSTEIN-BARR VIRUS INFECTIONS;
FEMALE;
HERPESVIRUS 4, HUMAN;
HUMANS;
IMMUNOHISTOCHEMISTRY;
IN SITU HYBRIDIZATION;
LYMPHOMA, B-CELL;
LYMPHOMA, LARGE-CELL, DIFFUSE;
PLASMACYTOMA;
RNA, VIRAL;
SKIN NEOPLASMS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
VINCRISTINE;
VIRAL MATRIX PROTEINS;
|
EID: 1642446543
PISSN: 01931091
EISSN: None
Source Type: Journal
DOI: 10.1097/00000372-200402000-00009 Document Type: Article |
Times cited : (7)
|
References (8)
|